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Cathepsin E is an endo-lysosomal aspartic proteinase exclusively present in immune system 
cells. Previous studies have shown that cathepsin E-deficient (CatE-/-) mice display aberrant 
immune responses such as atopic dermatitis and higher susceptibility to bacterial infection. 
However, the mechanisms underlying abnormal immune responses induced by cathepsin E 
deficiency are still unclear. In this study, we found that the cell-surface levels of chemotactic 
receptors including chemokine receptor (CCR)-2 and N-formyl peptide receptors (FPRs), were 
clearly diminished in CatE-/-macrophages compared with those in wild-type cells. Consistently, 
chemotaxis of CatE-/-macrophages to MCP-1 and N-formyl-methionyl-leucyl-phenylalanine was 
also decreased. Similar to the chemotactic receptors, the surface expressions of the adhesion 
receptors CD18 (integrin β2) and CD 29 (integrin β1) in CatE-/- macrophages were significantly 
decreased, thereby reducing cell attachment of CatE-/- macrophages. These results indicate that 







Cathepsin E (EC 3.4.23.34) is an intracellular aspartic proteinase, which is mainly localized 
in the endosomal/lysosomal compartments within cells (1−3). Since cathepsin E is 
predominantly expressed in immune-related cells, including macrophages, dendritic cells, and 
microglia, this enzyme has been speculated to be involved in the proteolysis of 
endosomal/lysosomal compartments in immune-related cells (4−6). We have previously 
generated cathepsin E-deficient (CatE-/-) mice that spontaneously developed atopic 
dermatitis-like skin lesions when reared under conventional conditions but not under specific 
pathogen-free conditions (7). These results imply that development of this disorder in these mice 
appeared to be triggered by some environmental factor(s) such as pathogenic microorganisms. 
Thereafter, we showed that CatE-/- mice exhibit increased susceptibility to infection with 
bacteria such as Staphylococcus aureus and Porphyromonas gingivalis (8). However, the 
molecular mechanisms inducing aberrant immune responses in CatE-/- mice remain to be 
elucidated.  
Recently, we demonstrated that peritoneal macrophages derived from CatE-/- mice 
display a novel type of lysosomal storage disorder characterized by the accumulation of major 
lysosomal membrane sialoglycoproteins such as lysosome-associated membrane protein 
(LAMP)-1 and LAMP-2, in the cells with a concomitant elevated lysosomal pH (9). Since an 
elevated pH is known to induce abnormal properties of endolysosomal compartments including 
abnormal processing and targeting of lysosomal proteins (10, 11) and abnormal maturation 
and/or fusion events of the acidic organelles (12), CatE-/- macrophages are assumed to show 
trafficking defects in both membrane and soluble proteins. Indeed, we found the enhanced 
secretion of soluble lysosomal enzymes by CatE-/- macrophages (9). In addition to soluble 
proteins, we reported decreased surface levels of Toll-like receptors (TLRs), which are capable 
of recognizing specific components of microorganisms, in CatE-/- macrophages, further we 
reported diminished cytokine production by CatE-/- macrophages that are stimulated by specific 
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TLR ligands (8). However, no information is available concerning the trafficking defects of 
receptors other than TLRs on the cell surface of CatE-/- macrophages.  
Macrophages express a large number of cell surface receptors, which recognize a wide 
range of specific endogenous and exogenous ligands (13). Among them, chemotactic receptors 
play an important role in immune responses (14). Recognition of chemoattractants by 
chemotactic receptors, which is known as chemotaxis, regulates leukocyte recruitment to sites of 
inflammation and infection (15, 16). The chemotactic receptors belong to the 
7-transmembrane-G-protein-coupled receptor family, and trigger various immune responses 
besides chemotaxis, induce the production of reactive oxygen species, and stimulate the release 
of proteolytic enzymes from granules, in the case of neutrophils (17). Concerning chemotactic 
responses, we have more recently reported that bone-marrow derived macrophages from CatE-/- 
mice display impaired chemotaxis in responses to a chemokine and a bacterial peptide (18). 
However, precise mechanisms of the diminished chemotaxis in CatE-/- macrophages remain 
unknown.  In addition to chemotactic receptors, leukocyte recruitment to inflammatory and 
infectious sites is orchestrated by cell-adhesion molecules (19). Cell-adhesion receptors are 
surface proteins involved in the binding of cells with other cells or the extracellular matrix (20, 
21). The cell-adhesion receptors belong to 4 major families, namely, the immunoglobulin 
superfamily, the cadherins, the selectins, and the integrins (22). In particular, the integrins, 
which are heterodimers formed by the two non-covalent linking 2 subunits α and β, are also 
involved in various intracellular signaling pathways as well as in cell attachment (20, 23). 
Therefore, it is of importance to investigate whether or not the chemotactic receptors and 
cell-adhesion receptors on the cell surface of CatE-/- macrophages are decreased. 
In this study, we focused on chemotaxis and cell adhesion in CatE-/- macrophages, and 
observed impaired chemotaxis and cell-adhesion ability in them with concomitant decreased 





Materials and Methods 
Materials  
RPMI-1640, fluorescein dextran (70,000 MW), and fluorescein conjugated chemotactic 
hexapeptide N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys were purchased from Invitrogen, Japan. 
Anti-mouse LAMP-1 and LAMP-2 antibodies were purchased from Southern Biotechnology Inc 
(Birmingham AL USA). Anti-mouse CCR2 monoclonal antibody conjugated with phycoerythin 
(PE) was purchased from R& D Systems Inc. Anti-mouse CD18 and CD29 monoclonal 
antibodies conjugated with fluorescein isothiocyanate (FITC) were purchased from BD 
Biosciences.  
Mice  
Wild-type and CatE-/- mice with the C57BL/6 genetic background were used as described 
previously (9). Animals were maintained under specific pathogen-free conditions according to the 
guidelines of the Japanese Pharmacological Society. Animals and all experiments were approved 
by the Animal and Microbiological Research Committee of the Graduate School of Dental 
Science, Kyushu University. All experiments were performed with age-matched, male CatE-/- 
mice and wild-type littermates. 
Preparation of peritoneal macrophages  
Thioglycolate-elicited peritoneal macrophages were isolated as described previously (9). Briefly, 
8-14 week-old mice were peritoneally injected with 4.05% thioglycolate (2 ml/mouse). Three and 
a half days later, peritoneal exudate cells were isolated from the peritoneal cavity by washing 
with phosphate buffered saline (PBS). The cells were incubated in RPMI 1640 medium 
supplemented with 10% penicillin (50 units/ml) and streptomycin (50 µg/ml) at 37 °C with 5% 
CO2. After incubation for 2 h, floating cells were removed by washing 3 times with 
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Ca2+/Mg2+-free PBS. MAC-2-positive macrophages comprised more than 95% of the isolated 
cells. 
Cell staining and flow cytometry  
The peritoneal macrophage suspension (2 × 105 cells/100 µl) was incubated on ice for 15 min 
with primary antibodies appropriately diluted with PBS containing 2.5% fetal bovine serum 
(FBS) and 0.01% NaN3 (buffer A). Samples were preincubated with Fc Block (anti-mouse 
CD16/CD32 antibody) (BD Pharmigen), and subsequently with specific antibodies or control 
antibodies conjugated with PE or FITC for 15 min on ice. In case of permeabilization, cells were 
prepared by treatment with 0.03 % saponin in buffer A for 15 min on ice. Flow cytometric 
analyses were performed on a Beckman Coulter Epics XL cytometer.  
Cell-adhesion assay 
Fibronectin (20 µg/ml) in RPMI medium or untreated medium (uncoated) was added in a 
96-well plate, and incubated overnight at 4°C. The wells were blocked with RPMI medium 
containing 0.5 % bovine serum albumin (BSA). After washing with RPMI medium containing 
0.1 % BSA (washing buffer), peritoneal macrophages (5× 105 cells) were added to each well and 
incubated at 37°C for 10, 20, or 30 min. Floating or weakly bound cells in the plate were gently 
removed by filling the wells 3 times with washing buffer. Bound cells were fixed with 4 % 
paraformaldehyde in PBS for 10 min. After washing, cells were stained with 50 µl of crystal 
violet (5 mg/ml in 2% ethanol). After washing 3 times with the washing buffer, the stained plate 
was assayed with a microplate reader at 540 nm. 
Chemotactic assay  
Chemotactic assay was performed as described previously (18). Briefly, peritoneal macrophages 
(2 × 105 cells/ml) were washed, and resuspended in RPMI medium. Migration of cells in 
response to the medium alone, MCP-1, or fMLP was assessed in a 24-well chemotaxis chamber 
separated by polyethylene terephthalate membrane (pore size, 8 µm). The macrophages were 
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loaded into the upper chambers and tested for chemoattraction to the media alone (RPMI-1640 
medium without FBS as a control medium), MCP-1(0.1 nM), or fMLP (1 µM). The chambers 
were incubated at 37°C in 5% CO2 for 90 min.  The cells that migrated into the lower wells 
were fixed with 4% paraformaldehyde in PBS for 10 min, subsequently stained with 
May-Giemsa, and then counted by light microscopy. 
Endocytosis assay 
Peritoneal macrophages (5 × 106 cells) were incubated with fluorescein dextran (20 µg/ml) in 
normal RPMI-1640 medium containing 10% FBS for 30 or 60 min. After washing with PBS 
containing 1mg/ml of BSA, cells were lysed in 50 mM Tris-HCl buffer (pH 8.5) containing 
0.1 % Triton X-100. The amounts of fluorescence in the cell lysates were measured by 
spectrofluorometry (Hitachi 650-40) and normalized to the total cell protein levels.  
Statistical analysis  
The statistical significance of differences was determined using the Student’s t test. 
 
RESULTS 
Impaired chemotaxis and decreased cell-surface levels of chemotactic receptors in CatE-/- 
macrophages 
During a series of experiments that we performed, we had assumed that the number of 
thioglycolate-elicited peritoneal macrophages in CatE-/- mice was possibly lower than that in the 
wild-type mice. Therefore, we accurately measured the number of thioglycolate-elicited 
peritoneal macrophages in the wild-type and CatE-/- mice. The number of peritoneal 
macrophages in the CatE-/- mice was significantly lower than that in the wild-type mice (Fig. 1), 
suggesting that chemotaxis or other chemotactic factor(s) might be more impaired in the CatE-/- 
mice than in the wild-type mice.  
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Recently, we reported that chemotactic responses of the bone- marrow- derived 
macrophages acquired from CatE-/- mice were significantly decreased compared with those from 
wild-type mice, whereas no marked differences were observed in the responses of bone- 
marrow- derived dendritic cells acquired from wild-type and CatE-/- mice (18). To further 
investigate the chemotaxis of peritoneal macrophages, we determined the chemotactic responses 
of wild-type and CatE-/- macrophages to the typical chemokine monocyte chemoattractant 
protein (MCP)-1. The number of CatE-/- macrophages that migrated from the upper to the lower 
chamber in response to MCP-1 was lower than that of the wild-type macrophages (Fig. 2). 
Similar results were observed in experiments with a bacterial-derived chemoattractant, 
N-formyl-methionyl-leucyl-phenylalanine (fMLP) (Fig. 2). These results of peritoneal 
macrophages in this study were quite consistent with previous results obtained with those of 
bone-marrow derived macrophages (18). In addition, we have investigated chemotaxis of 
resident peritoneal macrophages that were not activated by thioglycolate from wild-type and CatE-/- 
mice in response to MCP-1 and fMLP. However, the results of resident macrophages were 
essentially similar to those of thioglycolate-activated macrophages (Data not shown).  
To evaluate the cell-surface levels of chemotactic receptors on the wild-type and CatE-/- 
macrophages, we analyzed the surface expression of CCR2, which is the receptor for MCP-1, 
and N-formyl peptide receptors (FPRs), which are the receptors for several N-formyl peptides 
including fMLP, by flow cytometry. As shown in Fig. 3A, CatE-/- cells showed decreased levels 
of both CCR2 and FPR as compared with wild-type cells. However, this difference in receptor 
levels was abrogated with permeabilized cells that were pretreated with saponin, which enabled 
the detection of both intracellular and extracellular expression of proteins, indicating that the 




Reduced cell-adhesion ability and decreased cell surface levels of cell adhesion receptors in 
CatE-/- macrophages 
 To further examine the cell-surface levels of receptors other than TLRs and 
chemotactic receptors, we investigated the surface expressions of cell-adhesion receptors in 
peritoneal macrophages from wild-type and CatE-/- mice. Integrins are major cell-adhesion 
receptors; they are heterodimers composed of an α and β subunits (23). When we analyzed the 
cell-surface expression of CD18 (integrin β2 chain) on wild-type and CatE
-/- macrophages by 
flow cytometry, we observed that the surface expression of CD18 was reduced in CatE-/- 
macrophages compared with those of the wild-type cells (Fig.4A). Similarly, the surface levels 
of CD29 (integrin β1 chain) on CatE
-/- macrophages were more decreased than those of wild-type 
cells (Fig.4A). However, treatment with saponin showed no significant difference in the total 
expression levels of receptors between wild-type and CatE-/- macrophages (Fig. 4B). These 
results indicate that the surface levels of cell-adhesion receptors were also decreased in CatE-/- 
macrophages in spite of the similarity in the total expression levels of receptors between 
wild-type and CatE-/- macrophages. 
To test the adhesion abilities of wild-type and CatE-/- macrophages, we analyzed the 
attachment of cells to uncoated or fibronectin-coated plastic plates. It is known that both CD18 
and CD29 are involved in the interaction of these cells with plastics or fibronectin (24). At an 
early incubation time of 10 or 20 min, the density of bound CatE-/- macrophages was 
significantly lower than that of wild-type macrophages (Fig. 5). However, at a longer incubation 
time of 30 min, there were no marked differences in the cell density between wild-type and 
CatE-/- macrophages (Fig. 5A). When we analyzed the adhesion of macrophages to 
fibronectin-coated plates, we observed the density of attached CatE-/- macrophages to be 
diminished more than that of wild-type macrophages at 10 or 20 min of incubation (Fig. 5B). 
Taken together with the results of the adhesion assay and the flow cytometric analysis, the 
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reduced cell-adhesion ability in CatE-/- macrophages is probably due to the decreased surface 
levels of cell-adhesion receptors in CatE-/- cells.  
 
Decreased cell-surface levels of LAMP-1 and LAMP-2 in CatE-/- macrophages 
Our previous study showed that cathepsin E deficiency induces accumulation of 
LAMP-1 and LAMP-2 in the immune system cells (9). On the other hand, it is known that 
LAMPs are mainly localized in the limiting membranes of lysosomes and late endosomes; 
however, small amounts of LAMPs are also detectable on the cell surface (25, 26). Therefore, 
we assumed the possibility that the accumulation of LAMP-1 and LAMP-2 within the cells due 
to cathepsin E deficiency might cause decreased surface amounts of these lysosomal membrane 
proteins. We subsequently compared the surface levels of LAMPs between wild-type and CatE-/- 
macrophages. As shown in Fig. 6, flow cytometric analysis revealed that the surface levels of 
LAMP-1 and LAMP-2 were notably lower than those of wild-type cells. In contrast, treatment 
with saponin showed that the total expression levels of CatE-/- macrophages were higher than 
those of wild-type cells (data not shown). The data are consistent with previous data obtained 
with western blot or flow cytometric analysis performed to evaluate LAMP-1 and LAMP-2 
expression (9, 18). Thus, the surface expressions of LAMP-1 and LAMP-2 were also decreased 
in CatE-/- macrophages, probably because these lysosomal proteins accumulated in endosomes 
and lysosomes in CatE-/- cells (9).  
 
Normal endocytosis of FITC-dextran in CatE-/- macrophages 
We finally examined whether cathepsin E deficiency might affect the vesicle transport, 
including endocytosis, in addition to the membrane transport to the cell surface. We 
subsequently analyzed endocytosis in macrophages with FITC-dextran. After incubation at 30 or 
60 min, we measured the intracellular amounts of FITC-dextran in wild-type and CatE-/- 
macrophages by spectrofluorometry. However, there was no notable difference in the endocytic 
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efficiency of FITC-dextran between wild-type and CatE-/- macrophages (Fig. 7). We also found 
no significant difference between the endocytosis of wild-type and CatE-/- macrophages at 24 h 
of incubation time (data not shown).  Therefore, it appears probable that the cathepsin E 




 This study indicates that surface levels of CCR2 and FPRs chemotactic receptors, and 
CD18 and CD29 adhesion receptors were decreased in CatE-/- macrophages. Consistent with the 
reduced levels of chemotactic and adhesion receptors, the chemotactic and cell adhesion ability 
were also defective in CatE-/- macrophages. In addition to surface proteins, the surface levels of 
LAMP-1 and LAMP-2 were diminished in CatE-/- macrophages. However, the endocytosis of 
dextran in wild-type and CatE-/- macrophages was indistinguishable. Thus, the membrane 
trafficking of some receptors and membrane proteins to the cell surface and their functions were 
partially defective in CatE-/- macrophages. 
Our previous study has shown that cathepsin E deficiency induces accumulation of 
LAMP-1 and LAMP-2 accompanied by an elevation of lysosomal pH (9). Moreover, we have 
reported that the surface levels of TLR2 and TLR4 are decreased in CatE-/- macrophages, further 
we have reported that their cytokine production by CatE-/- macrophages in response to the 
specific TLR2 ligand (peptideglycan) and the TLR4 ligand (lipopolysaccharide) is diminished 
(8). However, this study demonstrated that surface levels of not only TLR, but also the 
chemotactic receptors and the adhesion receptors were decreased in CatE-/- macrophages. 
Importantly this study showed that the surface levels of LAMP-1 and LAMP-2 were also 
diminished in CatE-/- macrophages. Thus, cell-surface receptors and the surface expression of 
LAMP proteins are clearly attenuated in CatE-/- macrophages, implying an abnormal membrane 
trafficking of some proteins in CatE-/- cells. 
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 The abnormal membrane trafficking in CatE-/- cells is probably responsible for the 
accumulation of various lysosomal membrane sialoglycoproteins including LAMP-1 and 
LAMP-2. This is because cathepsin E deficiency induces a novel form lysosomal storage 
disorder characterized by the accumulation of LAMPs (9). Therefore, these accumulations in 
endosomes and lysosomes probably influence the defects in the trafficking of membrane proteins 
in endocytic pathways. Similar abnormal membrane trafficking is observed in other lysosomal 
storage diseases such as Gaucher disease (β-glucosidase deficiency) (27), Pompe diseases 
(α-glucosidase deficiency) (28), neuronal ceroid lipofuscinosis (CLN3 or battenin deficiency) 
(29), and Niemann-Pick type A or B disease (sphingomyelinase deficiency) (30). It has been 
proposed that accumulation of metabolites due to lack of a lysosomal enzyme causes a certain 
“traffic jam” in the endocytic pathways including those at the cell surface (31, 32). Moreover, it 
has been reported that the treatment of cells with substances that are indigestible by lysosomes, 
which induces lysosomal storage-like phenotypes, and results in the accumulation of the 
cell-surface proteins MUC1 and CD29 cell surface proteins in endocytic vesicles (33). Thus, in a 
manner analogous to these phenotypes of storage disorders, it is likely that cathepsin E 
deficiency primarily causes accumulation of LAMPs, secondarily leading to the abnormal 
membrane trafficking of LAMPs and other receptors to the cell surface. 
 The molecular mechanisms in which cathepsin E deficiency impairs chemotactic 
responses and cell-adhesion ability remain to be determined. However, several studies have 
reported that chemotaxis of cells from lysosomal storage diseases are clearly reduced in 
comparison with that of cells from normal humans.  For example, impaired chemotaxis was 
observed in cells from Gaucher disease (34) and mucolipidosis II (35). Given that cathepsin E 
deficiency leads to a lysosomal storage-like disorder in macrophages, it is possible that the lack 
of cathepsin E causes a defective chemotaxis similar to those lysosomal storage diseases.  
In contrast to abnormal membrane trafficking to the cell-surface, endocytosis was 
normally processed in CatE-/- cells. Consistent with the results of this study, the phagocytosis 
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of S. aureus in CatE-/- macrophages has been shown to be normal (8). However, compared with 
the wild-type cells, dendritic cells from CatE-/- mice exhibit enhanced phagocytosis and 
increased surface expression of the costimulatory molecules CD86, CD80 and CD40 (18). 
Although the precise mechanisms are still unknown, the discrepancy in phagocytosis and 
membrane trafficking between macrophages and dendritic cells from CatE-/- mice may be 
explained by the findings that dendritic cells have a specialized endocytic pathway, constituting 
specific compartments for antigen presentation such as the major histocompatibility complex II 
compartments and class II vesicles (34, 35).   
 In conclusion, the present study indicates impaired chemotactic and cell-adhesion 
ability in CatE-/- macrophages, probably due to the decreased cell surface levels of chemotactic 
and cell adhesion receptors.  
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Figure 1. Number of thioglycolate-elicited peritoneal macrophages derived from wild-type 
or CatE-/- mice. Mice were peritoneally injected with 4.05% thioglycolate (2 ml/mouse). Three 
and half days later, peritoneal exudate cells were isolated from the peritoneal cavity by washing 
with PBS. The cells were incubated with RPMI medium containing 10 % FBS at 37°C for 2 h, 
and subsequently washed 3 times with PBS. After removing cells with trypsin, the cell number 
was determined by light microcopy using Burker-Turk hemocytometer chambers. The data are 
means + SD for five independent experiments. **P < 0.01, versus the corresponding values for 
the wild-type littermates, obtained with the unpaired Student’s t test.  
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Figure 2. Chemotaxis of peritoneal macrophages from wild-type or CatE-/- mice in response 
to MCP-1 and fMLP. Peritoneal macrophages were washed, and resuspended in RPMI-1640 
medium without FBS as a control medium. Migration of cells in response to a concentration of 
MCP-1 (0.1 nM), and fMLP (1 µM) was assessed in a 24-well Transwell chemotaxis chamber. 
The chambers were incubated at 37°C for 90 min. The cells that migrated to the lower well were 
fixed-, and subsequently stained with trypan blue, and then counted by light microscopy. The 
data are means + SD for five independent experiments.*P < 0.05, versus the corresponding 
values for the wild-type macrophages, obtained with the unpaired Student’s t test.  
 
Figure 3. Flow cytometric analysis of expression levels of CCR2 and FPRs in wild-type or 
CatE-/- macrophages. (A) Peritoneal macrophages (2 × 105 cells) from wild-type and CatE-/- 
mice were stained for cell surface with a specific antibody for CCR2 conjugated with PE, or 
with N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys-fluorescein, and then analyzed by flow cytometry. 
Data are representative of five independent experiments. (B) The cells were permeabilized with 
saponin, and then stained for determination of the total expression levels of CCR2 or FPRs. Data 
are representative of 5 independent experiments. 
 
Figure 4. Expression levels of CD18 and CD29 in wild-type or CatE-/- macrophages. (A) 
Macrophages (2 × 105 cells) from wild-type and CatE-/- mice were stained for the cell surface 
with specific antibodies for CD18 and CD29, subsequently treated with FITC-labeled second 
antibodies, and then analyzed by flow cytometry. Data are representative of five independent 
experiments. (B) The cells were permeabilized with saponin and then stained for determination 




Figure 5. Cell adhesion of wild-type and CatE-/- macrophages on uncoated or 
fibronection-treated plates.  Peritoneal macrophages (5 × 105 cells) were added to uncoated or 
fibronectin-treated plastic wells, and subsequently incubated at 37°C for 10, 20 or 30 min. After 
washing, bound cells were fixed with 4 % paraformaldehyde in PBS, and then stained with 
crystal violet. The stained plates were assayed with a microplate reader at 540 nm. The data are 
means + SD for four independent experiments. *P < 0.05, versus the corresponding values 
obtained with the wild-type macrophages, obtained with the unpaired Student’s t test.  
 
Figure 6. Surface expressions of LAMP-1 and LAMP-2 in wild-type or CatE-/- 
macrophages. Macrophages (2 × 105 cells) from wild-type and CatE-/- mice were stained for the 
cell surface with specific antibodies for LAMP-1 and LAMP-2, subsequently treated with 
FITC-labeled second antibodies, and then analyzed by flow cytometry. Data are representative 
of five independent experiments. 
Figure 7. Endocytosis of FITC-dextran by wild-type or CatE-/- macrophages. Macrophages 
(5 × 106 cells) were incubated with FITC-dextran (20 µg/ml) for 30 or 60 min. After washing, 
cells were lysed in 50 mM Tris-HCl buffer (pH 8.5) containing 0.1 % Triton X-100. The 
amounts of fluorescence in the cell lysates were measured by spectrofluorometry and normalized 
to the total cell protein concentration.  
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